| Raymond M Beyda, MD | |
|
1 Brookdale Plz, Brooklyn, NY 11212-3139 | |
| (718) 913-1344 | |
| Not Available |
| Full Name | Raymond M Beyda |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1 Brookdale Plz, Brooklyn, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215343991 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 303091 (New York) | Secondary |
| 207P00000X | Emergency Medicine | 303091 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Raymond M Beyda, MD 108 Dean St, Brooklyn, NY 11201-6311 Ph: (718) 913-1344 | Raymond M Beyda, MD 1 Brookdale Plz, Brooklyn, NY 11212-3139 Ph: (718) 913-1344 |
News Archive
The Australasian College of Cosmetic Surgery update regarding French breast implant recall which may affect some Australian women
On September 22, construction of phase I of Genovate Biotechnology's Insulin Ecological Industrial Park began in Changzhou National Hi-tech District. Changzhou mayor Fei Gaoyun said the city and district governments and the relevant oversight authorities will do their best to provide support services, with the aim of doing what is needed to see construction completed and the facility put into production as early as possible.
Over the years, all terrain vehicles (ATVs) and motocross motorcycles have gained popularity and marketed as toys to consumers. These high-velocity machines can weigh between 300 and 600 pounds, and run on average between 25 and 60 miles per hour, while some even reach maximum speeds of 75 miles per hour.
Syracuse University researchers have designed, tested and patented a new method of oral insulin delivery that can potentially help reduce daily insulin injections for millions of people with diabetes who require therapy for optimal glycemic control.
AstraZeneca today announced positive results from the Phase III DECLARE-TIMI 58 cardiovascular outcomes trial for FARXIGA, the broadest SGLT-2 inhibitor CVOT conducted to date.
› Verified 1 days ago
Snehalata R Topgi, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 450 Clarkson Ave, Brooklyn, NY 11203 Phone: 718-270-3295 Fax: 718-221-6377 | |
Madi Lindauer, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Brookdale Plz, Brooklyn, NY 11212 Phone: 718-240-5000 | |
Dr. Enid Naamomo Otoo, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Brookdale Plz, Brooklyn, NY 11212 Phone: 718-240-7225 | |
Zachary Paul Funk, M.D Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4802 10th Ave, Brooklyn, NY 11219 Phone: 718-283-6000 | |
Tejeshwer Jaswal, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2601 Ocean Parkway, Brooklyn, NY 11235 Phone: 929-310-4050 | |
Branidia Paulina Mercedes, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 374 Stockholm St, Brooklyn, NY 11237 Phone: 718-963-7711 | |
Mr. Gregory Ginsburg, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 506 6th St, Brooklyn, NY 11215 Phone: 718-780-3000 |